XML 35 R25.htm IDEA: XBRL DOCUMENT v3.7.0.1
COMMON STOCK AND STOCK-BASED COMPENSATION PLANS (Tables)
6 Months Ended
Jun. 30, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Summary of Stock Option Activity

A summary of the Company’s stock option and SARs activities and related information for the six months ended June 30, 2017, are as follows:

 

     Number of
options and
SAR units (1)
     Weighted
average
exercise

price
     Weighted
average
remaining

contractual
term
     Aggregate
intrinsic-value
 

Outstanding as of December 31, 2016

     1,455,908      $ 19.76        

Granted

     —          —          

Exercised

     (572,520      19.72        

Forfeited or expired

     (12,514      17.58        
  

 

 

    

 

 

       

Outstanding as of June 30, 2017 (2)

     870,874      $ 19.82        5.4      $ 22,324  
  

 

 

    

 

 

    

 

 

    

 

 

 

Exercisable as of June 30, 2017 (3)

     565,168      $ 19.08        4.7      $ 14,902  
  

 

 

    

 

 

    

 

 

    

 

 

 

 

(1) The SAR units are convertible for a maximum number of shares of the Company’s common stock equal to 75% of the SAR units subject to the grant.
(2) Due to the ceiling imposed on the SAR grants, the outstanding amount equals a maximum of 790,118 shares of the Company’s common stock issuable upon exercise.
(3) Due to the ceiling imposed on the SAR grants, the exercisable amount equals a maximum of 515,026 shares of the Company’s common stock issuable upon exercise.
Summary of Restricted Stock Units Activity

A summary of the Company’s RSU activities and related information for the six months ended June 30, 2017, are as follows:

 

     Number of
RSUs
     Weighted Average
Grant-Date

Fair Value
 

Unvested as of December 31, 2016

     505,142      $ 21.59  

Granted

     224,600        35.21  

Vested

     (166,208      20.45  

Forfeited or expired

     (18,438      23.58  
  

 

 

    

 

 

 

Unvested as of June 30, 2017

     545,096      $ 27.48  
  

 

 

    

 

 

 
Equity-Based Compensation Expense Included in Interim Condensed Consolidated Statements of Income

The following table shows the total equity-based compensation expense included in the interim condensed consolidated statements of income:

 

     Six months ended
June 30,
     Three months ended
June 30,
 
     2017      2016      2017      2016  
     (unaudited)      (unaudited)      (unaudited)      (unaudited)  

Cost of revenue

   $ 205      $ 114      $ 114      $ 54  

Research and development, net

     1,843        1,421        972        775  

Sales and marketing

     659        502        370        255  

General and administrative

     1,420        1,046        722        525  
  

 

 

    

 

 

    

 

 

    

 

 

 

Total equity-based compensation expense

   $ 4,127      $ 3,083      $ 2,178      $ 1,609  
  

 

 

    

 

 

    

 

 

    

 

 

 
Assumptions Used to Estimate Fair Value of Employee Stock Purchase Plan

The fair value for rights to purchase shares of common stock under the Company’s employee stock purchase plan was estimated on the date of grant using the following assumptions:

 

     Six months ended  
     June 30,  
     2017     2016  
     (unaudited)     (unaudited)  

Expected dividend yield

     0     0

Expected volatility

     35%-46     36%-57

Risk-free interest rate

     0.5%-0.7     0.3%-0.5

Expected forfeiture

     0     0

Contractual term of up to

     24 months       24 months